Activated prothrombin complex concentrate for reversal of oral factor Xa inhibitors at a level 1 trauma center

被引：1
|
作者：
Bobby, Lauren [1 ]
Westlake, Evan [1 ]
Esplin, Nathan [2 ]
Young, Sarah [1 ]
机构：
[1] Allegheny Gen Hosp, Dept Pharm, 320 North Ave, Pittsburgh, PA 15212 USA
[2] Allegheny Gen Hosp, Dept Neurosurg, 320 North Ave, Pittsburgh, PA 15212 USA
来源：
THROMBOSIS RESEARCH | 2021年 / 206卷
关键词：
Apixaban; Rivaroxaban; Reversal; Activated prothrombin complex concentrate (aPCC); Intracranial hemorrhage (ICH); Andexanet alfa; ANTICOAGULANTS; MANAGEMENT; OUTCOMES; FEIBA;
D O I：
10.1016/j.thromres.2021.08.005
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
[No abstract available]
引用
收藏
页码：33 / 35
页数：3
相关论文
共 50 条
  • [41] Reversal of oral anticoagulation with prothrombin complex concentrate (Octaplex)
    H Riess
    A Meier-Hellmann
    J Motsch
    M Elias
    F Kursten
    C Dempfle
    Critical Care, 11 (Suppl 2):
  • [42] FIXED-DOSE FOUR-FACTOR PROTHROMBIN COMPLEX CONCENTRATE IN WARFARIN AND FACTOR XA INHIBITOR REVERSAL
    Kim, Ji-Yeon
    Berg-Lewis, David
    Amoateng, Ricky
    CRITICAL CARE MEDICINE, 2024, 52
  • [43] Evaluation of three-factor prothrombin complex concentrate versus four-factor prothrombin complex concentrate for the urgent reversal of oral anticoagulation.
    Truong, Shawna
    Snyder, Julie
    Celmins, Laura
    PHARMACOTHERAPY, 2017, 37 (06): : E47 - E47
  • [44] Four-factor Prothrombin Complex Concentrate for the Management of Patients Receiving Direct Oral Activated Factor X Inhibitors
    Grottke, Oliver
    Schulman, Sam
    ANESTHESIOLOGY, 2019, 131 (05) : 1153 - 1165
  • [45] Outcomes of activated prothrombin complex concentrate for direct Xa inhibitor bleeding
    Smythe, Maureen A.
    Koerber, John M.
    Hoffman, Janet L.
    Mertz, Sean
    Fritsch, Karissa
    Chehab, Fatme
    Baalbaki, Nour
    Krishnan, Anant
    THROMBOSIS RESEARCH, 2021, 206 : 142 - 144
  • [46] More efficient reversal of dabigatran inhibition of coagulation by activated prothrombin complex concentrate or recombinant factor VIIa than by four-factor prothrombin complex concentrate
    Lindahl, Tomas L.
    Wallstedt, Maria
    Gustafsson, Kerstin M.
    Persson, Egon
    Hillarp, Andreas
    THROMBOSIS RESEARCH, 2015, 135 (03) : 544 - 547
  • [47] EVALUATION OF WARFARIN REVERSAL WITH 4-FACTOR PROTHROMBIN COMPLEX CONCENTRATE COMPARED TO 3-FACTOR PROTHROMBIN COMPLEX CONCENTRATE AT A TERTIARY ACADEMIC MEDICAL CENTER
    Al-Majzoub, Omar
    Rybak, Eva
    Reardon, David P.
    Krause, Patricia
    Connors, Jean M.
    JOURNAL OF EMERGENCY MEDICINE, 2016, 50 (01): : 7 - 13
  • [48] Reversal of Dabigatran Anticoagulation by using Activated Prothrombin Complex Concentrate
    Agaronov, M.
    Logdberg, L. E.
    Fayyaz, K.
    Louie, J.
    Shafeeq, H.
    Lee, D. C.
    Jean-Louis, J.
    Nikolis, N. M.
    Heaton, W.
    Chhibber, V.
    TRANSFUSION, 2015, 55 : 167A - 167A
  • [49] Clinical experience reversing factor Xa inhibitors with four-factor prothrombin complex concentrate in a community hospital
    Tellor, Katie B.
    Barasch, Naomi S.
    Lee, Brian M.
    BLOOD TRANSFUSION, 2018, 16 (04) : 382 - 386
  • [50] Utilization of 4-Factor Prothrombin Complex Concentrate for Reversal of Oral Factor Xa Inhibitor-Associated Acute Major Bleeding: A Case Series
    Reynolds, Tessa R.
    Gilbert, Brian W.
    Hall, Katherine M.
    JOURNAL OF PHARMACY PRACTICE, 2021, 34 (05) : 755 - 760
12345